The data presented in the Thakur study with the TAp73-deficient GEMM suggest that TAp73 efficiently prevents a switch in TGF-β function from tumor-suppressive to tumor-promoting and that this switch also involves secreted factors acting in an autocrine/paracrine fashion. This evidence concerns the gene TGFB1 and neoplasm.